Abstract
Olanzapine does not demonstrate advantages compared with haloperidol (in combination with prophylactic benztropine) in compliance, symptoms, extrapyramidal symptoms, or overall quality of life, and its benefits in reducing akathisia and improving cognition must be balanced with the problems of weight gain and higher cost.
Keywords
OlanzapineMedicineVeterans AffairsAkathisiaSchizoaffective disorderSchizophrenia (object-oriented programming)PsychiatryRandomized controlled trialHaloperidolTardive dyskinesiaAntipsychoticExtrapyramidal symptomsNeurocognitiveAdverse effectRandomizationInternal medicinePsychosisCognition
Affiliated Institutions
Related Publications
Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis
Weight gain is a clinically important side effect of antipsychotic drug therapy. The aim of this study was to determine the effect of the antidiabetic drug metformin on antipsyc...
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
The oligometastatic paradigm suggests that some patients with a limited number of metastases might be cured if all lesions are eradicated. Evidence from randomised controlled tr...
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
PURPOSE The oligometastatic paradigm hypothesizes that patients with a limited number of metastases may achieve long-term disease control, or even cure, if all sites of disease ...
Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke
Background and Purpose— The National Institutes of Health (NIH) estimates that stroke costs now exceed $45 billion per year. Stroke is the third leading cause of death and one o...
Publication Info
- Year
- 2003
- Type
- article
- Volume
- 290
- Issue
- 20
- Pages
- 2693-2693
- Citations
- 315
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
315
OpenAlex
Cite This
Robert A. Rosenheck
(2003).
Effectiveness and Cost of Olanzapine and Haloperidol in the Treatment of Schizophrenia<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>.
JAMA
, 290
(20)
, 2693-2693.
https://doi.org/10.1001/jama.290.20.2693
Identifiers
- DOI
- 10.1001/jama.290.20.2693